Advertisement
Advertisement

KTTA

KTTA logo

Pasithea Therapeutics Corp. Common Stock

0.48
USD
Sponsored
+0.01
+1.69%
Aug 11, 12:43 UTC -4
Open

Pasithea Therapeutics Corp. Common Stock Profile

About

Pasithea Therapeutics Corp. is a biotechnology company. It focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Pasithea Therapeutics Corp. is based in MIAMI BEACH, Fla.

Info & Links

CEO

Tiago Reis Marques

Headquarters

1111 Lincoln Road, Suite 500
Miami Beach, FL 33139, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.pasithea.com

Auditor

CBIZ CPAs P.C.

Share holders

37

Employees

5

Pasithea Therapeutics Corp. Common Stock Statistics

Valuation Measures

Market Capitalization2

16.11M

Enterprise Value

-34.40M

Enterprise Value/EBITDA(ttm)

1.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.23

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-57.44%

Return on Invested Capital(ttm)

-72.91%

Return on Assets(ttm)

-53.61%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-21.40M

Net Income Available to Common(ttm)

-19.73M

Diluted EPS(ttm)

-2.08

Share Statistics

Beta (5Y Monthly)

0.29

52-Week Change

-29.33%

S&P 500 52-Week Change

21.39%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

33.41M

Dividend Yield

0.00%

Float4

32.75M

% Held by Insiders

2.00%

% Held by Institutions

23.92%

Balance Sheet

Total Cash(mrq)

50.50M

Total Cash Per Share(mrq)

1.51

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

35.40%

Quick Ratio(mrq)

35.41%

Book Value Per Share(mrq)

2.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.20

Free Cash Flow(ytd)

-4.79M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement